GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Altimmune Inc (STU:3G0) » Definitions » Shiller PE Ratio

Altimmune (STU:3G0) Shiller PE Ratio : (As of Jun. 05, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Altimmune Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Altimmune Shiller PE Ratio Historical Data

The historical data trend for Altimmune's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Altimmune Shiller PE Ratio Chart

Altimmune Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Altimmune Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Altimmune's Shiller PE Ratio

For the Biotechnology subindustry, Altimmune's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Altimmune's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Altimmune's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Altimmune's Shiller PE Ratio falls into.



Altimmune Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Altimmune's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Altimmune's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.313/131.7762*131.7762
=-0.313

Current CPI (Mar. 2024) = 131.7762.

Altimmune Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -2.208 100.560 -2.893
201409 -18.624 100.428 -24.437
201412 -9.732 99.070 -12.945
201503 5.544 99.621 7.333
201506 -10.692 100.684 -13.994
201509 -5.346 100.392 -7.017
201512 -5.508 99.792 -7.273
201603 -5.388 100.470 -7.067
201606 -6.675 101.688 -8.650
201609 -18.978 101.861 -24.552
201612 -13.082 101.863 -16.924
201703 -19.074 102.862 -24.436
201706 -6.942 103.349 -8.851
201709 -51.657 104.136 -65.368
201712 -13.647 104.011 -17.290
201803 -6.074 105.290 -7.602
201806 -8.808 106.317 -10.917
201809 -1.483 106.507 -1.835
201812 -2.449 105.998 -3.045
201903 -0.239 107.251 -0.294
201906 -0.230 108.070 -0.280
201909 -0.672 108.329 -0.817
201912 -0.225 108.420 -0.273
202003 -0.235 108.902 -0.284
202006 -0.835 108.767 -1.012
202009 -0.458 109.815 -0.550
202012 -0.140 109.897 -0.168
202103 -0.319 111.754 -0.376
202106 -0.498 114.631 -0.572
202109 -0.689 115.734 -0.785
202112 -0.504 117.630 -0.565
202203 -0.400 121.301 -0.435
202206 -0.397 125.017 -0.418
202209 -0.485 125.227 -0.510
202212 -0.406 125.222 -0.427
202303 -0.374 127.348 -0.387
202306 -0.295 128.729 -0.302
202309 -0.365 129.860 -0.370
202312 -0.514 129.419 -0.523
202403 -0.313 131.776 -0.313

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Altimmune  (STU:3G0) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Altimmune Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Altimmune's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Altimmune (STU:3G0) Business Description

Traded in Other Exchanges
Address
910 Clopper Road, Suite 201S, Gaithersburg, MD, USA, 20878
Altimmune Inc is engaged on developing treatments for obesity and liver diseases. The Company's pipeline includes next generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Altimmune (STU:3G0) Headlines

No Headlines